Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.

Robert Orlowski, MD, PhD, Heather Sutherland, MD, PhD, Joan Bladé, MD, Jesús San Miguel, MD, Roman Hájek, MD, PhD, Arnon Nagler, MD, MSc, Pieter Sonneveld, MD, PhD, Andrew Spencer, DM, Tadeusz Robak, MD, PhD, Suneel Mundle, PhD, Donghan Luo, PhD, Sen Hong Zhuang, MD, PhD, Jean-Luc Harousseau, MD

Blood (2007) 110 (11): 2735.

https://doi.org/10.1182/blood.V110.11.2735.2735

Published: 2007

Journal Articles

Anti-Thymocyte Globulin Induces Higher Response Rates and Less Graft-Versus-Host Disease in Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplantation.

Francis Ayuk, MD, José A. Perez-Simon, MD, Avichai Shimoni, MD, Anna Sureda, MD, Tatjana Zabelina, MD, Rainer Schwerdtfeger, MD, Rodrigo Martino, MD, Herbert G. Sayer, MD, Adrián Alegre, MD, Juan-José Lahuerta, MD, Djordje Atanackovic, MD, Christine Wolschke, MD, Arnon Nagler, MD, Axel R. Zander, MD, Jesús San Miguel, MD, Nicolaus Kroeger, MD

Blood (2007) 110 (11): 2980.

https://doi.org/10.1182/blood.V110.11.2980.2980

Published: 2007

Journal Articles

Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines

Belén Blanco, José A. Pérez-Simón, Luis I. Sánchez-Abarca, Xonia Carvajal-Vergara, Juan Mateos, Belén Vidriales, Natalia López-Holgado, Patricia Maiso, Mercedes Alberca, Eva Villarón, David Schenkein, Atanasio Pandiella, Jesús San Miguel

Blood (2006) 107 (9): 3575–3583.

https://doi.org/10.1182/blood-2005-05-2118

Published: 2006

Journal Articles

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA

Blood (2005) 106 (12): 3755–3759.

https://doi.org/10.1182/blood-2005-03-1301

Published: 2005

Journal Articles

Minimal Residual Disease (MRD) Evaluation by Flow Cytometry in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

Maria-Belen Vidriales, MD, PhD, Jose J. Pérez, Consuelo López-Berges, MD, PhD, Norma C. Gutierrez, MD, PhD, Juana Ciudad, PhD, Lourdes Vazquez, MD, PhD, Consuelo del Cañizo, MD, PhD, Joaquín Díaz-Mediavilla, MD, PhD, Javier Fernández-Calvo, MD, Fernando Ramos, MD, PhD, María Jesús Rodriguez, MD, PhD, María José Calmuntia, MD, PhD, Alberto Orfao, MD, PhD, Jesús San Miguel, MD, PhD

Blood (2004) 104 (11): 1103.

https://doi.org/10.1182/blood.V104.11.1103.1103

Published: 2004

Journal Articles

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes

Rodrigo Martino, Marı́a Dolores Caballero, José Antonio Pérez Simón, Carmen Canals, Carlos Solano, Alvaro Urbano-Ispı́zua, Joan Bargay, Angel Léon, Josep Sarrá, Guillermo F. Sanz, José Marı́a Moraleda, Salut Brunet, Jesús San Miguel, Jorge Sierra

Blood (2002) 100 (6): 2243–2245.

https://doi.org/10.1182/blood-2002-02-0400

Published: 2002

NARROW

Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.

Anti-Thymocyte Globulin Induces Higher Response Rates and Less Graft-Versus-Host Disease in Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplantation.

Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA

Minimal Residual Disease (MRD) Evaluation by Flow Cytometry in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes

Email alerts

ASH Publications

American Society of Hematology

Early Normalization of Serum Free Light Chain Is Associated with Prolonged Time to Progression Following Bortezomib ± Pegylated Liposomal Doxorubicin Treatment of Relapsed/Refractory Multiple Myeloma.

Anti-Thymocyte Globulin Induces Higher Response Rates and Less Graft-Versus-Host Disease in Multiple Myeloma Patients Undergoing Allogeneic Stem Cell Transplantation.

Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines

High-dose therapy intensification compared with continued standard chemotherapy in multiple myeloma patients responding to the initial chemotherapy: long-term results from a prospective randomized trial from the Spanish cooperative group PETHEMA

Minimal Residual Disease (MRD) Evaluation by Flow Cytometry in Acute Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only